Document and Entity Information Entity Addresses [Table] Class of Stock [Axis] Class of Stock [Domain] Common Stock [Member] Ordinary Shares ADR [Member] ADS Entity Addresses [Line Items] Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address State Or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(g) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Consolidated Balance Sheets Statement [Table] Statement [Line Items] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash balance Short-Term Investments Investments Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total Interest Payable, Current Accrued interest and financing expense Other Liabilities, Current Less: Short-term portion Due to officers - short term Other Liability, Current, Related Party, Type [Extensible Enumeration] Other liability, current, related party, type extensible enumeration Liabilities, Current Total current liabilities Other Liabilities, Noncurrent Long-term portion Due to officers - long term Other Liability, Noncurrent, Related Party, Type [Extensible Enumeration] Other liability, noncurrent, related party, type extensible enumeration Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies Stockholders' Equity Attributable to Parent [Abstract] Shareholders' equity: Common Stock, Value, Issued Ordinary shares, no par value per share, 5,000,000,000 authorized at March 31, 2026 and December 31, 2025, respectively - 68,642,195 (1,961,206 ADS's) ordinary shares issued and outstanding at March 31, 2026 and 52,441,360 (1,498,325 ADS's) ordinary shares issued and outstanding at December 31, 2025 Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Additional Paid in Capital Additional paid in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Balance at end of year Balance at beginning of year Total shareholders' equity Liabilities and Equity Total liabilities and shareholders' equity Common Stock, Par or Stated Value Per Share Ordinary shares, par value Common Stock, Shares Authorized Ordinary shares, shares authorized Common Stock, Shares, Issued Ordinary shares, shares issued Common Stock, Shares, Outstanding Balance at ending of year (in shares) Balance at beginning of year (in shares) Ordinary shares, shares outstanding Condensed Consolidated Statements of Operations and Other Comprehensive Loss Operating Expenses [Abstract] Operating expenses Selling, General and Administrative Expense General and administrative Research and Development Expense Research and development Total research and development expenses Operating Costs and Expenses Total operating expenses Other (income) and expenses Unrealized Gain (Loss) on Derivatives Unrealized (gain) loss Investment Income, Interest and Dividend Realized and accrued interest income Nonoperating Income (Expense) Total other income Net loss Net loss Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive loss Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation Cumulative Translation Adjustment Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Earnings Per Share, Basic and Diluted [Abstract] Loss per ADS Earnings Per Share, Basic Basic Earnings Per Share, Diluted Fully-diluted Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average number of ADS's outstanding Weighted Average Number of Shares Outstanding, Basic Basic Weighted Average Number of Shares Outstanding, Diluted Fully-diluted Condensed Consolidated Statements of Shareholders' Equity Equity Components [Axis] Equity Component [Domain] Additional Paid-in Capital [Member] Additional Paid in Capital Retained Earnings [Member] Accumulated Deficit AOCI Attributable to Parent [Member] Accumulated other comprehensive loss Value of stock issued as a result of the exercise of warrants. Stock Issued During Period, Value, Warrants Exercised Exercise of pre-funded warrants and warrants, net Shares of stock issued as a result of the exercise of warrants. Stock Issued During Period, Shares, Exercise of Warrants Exercise of pre-funded warrants and warrants, net (in shares) APIC, Share-based Payment Arrangement, Increase for Cost Recognition Stock based compensation Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows used in operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Share-based Payment Arrangement, Noncash Expense Stock based compensation Amortization of Intangible Assets Amortization of intangibles Amortization expense of intangibles Amount of accrued interest, realized and unrealized gain (loss) on investments. Investments, Accrued Interest, Realized And Unrealized Gain (Loss) Realized and unrealized gain and accrued interest on investments Increase (Decrease) in Operating Capital [Abstract] Changes in assets and liabilities: Increase (Decrease) in Accounts Payable and Accrued Expenses Increase (decrease) in accounts payable and accrued expenses Increase (Decrease) in Prepaid Expense Decrease (increase) in prepaid expenses and other assets Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows provided by investing activities: Payments to Acquire Investments Purchase of investments Proceeds from Sale, Maturity and Collection of Investments Proceeds from redemption of investments Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows provided by financing activities: Repayments of Related Party Debt Payment of amounts due to officers Non-bearing interest indebtedness Proceeds from Warrant Exercises Warrants gross proceeds Proceeds from exercise of warrants, net Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Effect of foreign exchange rate on changes on cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net change in cash and cash equivalents: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents - end of period Cash and cash equivalents - beginning of period ORGANIZATION AND BUSINESS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] ORGANIZATION AND BUSINESS No definition available. LIQUIDITY RISKS AND OTHER UNCERTAINTIES Substantial Doubt about Going Concern [Text Block] LIQUIDITY RISKS AND OTHER UNCERTAINTIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ACCRUED INTEREST AND FINANCING EXPENSE The entire disclosure pertaining to accrued interest and financing expense. Accrued Interest and Financing Expense[Text Block] ACCRUED INTEREST AND FINANCING EXPENSE FAIR VALUE OF FINANCIAL INSTRUMENTS Fair Value Disclosures [Text Block] FAIR VALUE OF FINANCIAL INSTRUMENTS STOCK BASED COMPENSATION Share-based Payment Arrangement [Text Block] STOCK BASED COMPENSATION PREPAID EXPENSES The entire disclosure for current and non-current prepaid expenses. Prepaid Expense Disclosure Text Block PREPAID EXPENSES ACCRUED EXPENSES Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] ACCRUED EXPENSES IN-LICENSED TECHNOLOGY Asset Acquisition [Text Block] IN-LICENSED TECHNOLOGY INTANGIBLE ASSETS Intangible Assets Disclosure [Text Block] INTANGIBLE ASSETS RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS RESEARCH AGREEMENTS AND COMMITMENTS Commitments Disclosure [Text Block] RESEARCH AGREEMENTS AND COMMITMENTS SHAREHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] SHAREHOLDERS' EQUITY CONTINGENCIES Contingencies Disclosure [Text Block] CONTINGENCIES No definition available. LICENSE AGREEMENTS The entire disclosure for license agreements. License Agreements [Disclosure Text Block] LICENSE AGREEMENTS Basis of Accounting, Policy [Policy Text Block] Basis of Presentation: Consolidation, Policy [Policy Text Block] Principles of Consolidation: Use of Estimates, Policy [Policy Text Block] Use of Estimates: Segment Reporting, Policy [Policy Text Block] Operating Segment: Earnings Per Share, Policy [Policy Text Block] Earnings (loss) per share: Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of research and development expenses Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] FAIR VALUE OF FINANCIAL INSTRUMENTS Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of assets and liabilities measured at fair value on a recurring basis Share-based Payment Arrangement, Option, Activity [Table Text Block] Summary of stock-based activities under the Amended & 2025 Plans Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of weighted average assumptions of stock options granted valued using the Black-Scholes option-pricing model Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of Prepaid expenses Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of intangible assets Schedule of Related Party Transactions [Table Text Block] Schedule of amounts due to officers Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of warrants outstanding Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] ORGANIZATION AND BUSINESS Represents the number of clinical sites. Number Of Clinical Sites Number of clinical sites Number of commercial partnership entered by the company. Number Of Commercial Partnerships Entered Commercial partnership entered Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single reportable segment Segment Reporting Information [Line Items] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Number of Reportable Segments Number of reportable segments Number of Operating Segments Number of operating segments Amount of expense for research and development pursuant to external clinical development. Research and Development Expense, External Clinical Development External clinical development expenses Amount of expense for research and development pursuant to personnel related and stock-based compensation. Research and Development Expense, Personnel Related And Stock Based Compensation Personnel related and stock-based compensation Other Research and Development Expense Other research and development expenses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] This member represents outstanding warrants. Outstanding Warrants [Member] Outstanding warrants Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information related to pre funded warrants. Pre Funded Warrants [Member] Pre-funded warrants Pre-Funded Warrants Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of prefunded warrants. Incremental Common Shares Attributable To Dilutive Effect Of Pre Funded Warrants Unexercised prefunded warrants Schedule of Long-term Debt Instruments [Table] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Convertible Debt Convertible Notes issued in 2020. Convertible notes 2020 Convertible notes 2020 Convertible Notes Warrants, Common Stock. Convertible Notes Warrants, Common Stock Convertible notes warrants, common stock Related Party [Axis] Related Party [Domain]